Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients

Anthracycline adjuvant therapy has taken a particular role in the treatment of early stage breast cancer with an associated decrease in rates of both relapse and death. Their success however has been limited by their myelosuppression and their well-established risk of cardiac dysfunction.